Sharechat Logo

Kiwi Property Group Limited (NZX: KPG) Appoints New GM Funds Management

Tuesday 2nd February 2021

Text too small?

Kiwi Property has today announced the appointment of Steve Penney as General Manager Funds Management.

Steve brings 20 years of investment and finance experience to the role, including most recently as General Manager, Investment, at Stride Property Group, where he was instrumental in the development and execution of the company’s funds management strategy. Prior to this, Steve worked as Investment Director and Partner at H.R.L Morrison & Co Limited and Associate Director at PwC.

Kiwi Property CEO, Clive Mackenzie, said: “Funds management is a key opportunity for Kiwi Property and Steve’s addition to the team will enable us to accelerate our delivery in this area.

“We’re delighted to be welcoming an investment professional of Steve’s calibre to the business and look forward to benefitting from his significant expertise, as we continue to progress our funds management strategy.”

Please see the links below for more details:

Kiwi Property appoints new GM Funds Management

Source: Kiwi Property Group Limited



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Meridian Energy monthly operating report for July 2022
Cannasouth to launch a pro-rata renounceable rights issue
August 12th Morning Report
2022 Annual Shareholders' Meeting & Director Nominations
Rakon 2022 Annual Meeting Chair's Address and Presentation
VHP - Full year results release
RAKON FY23 Earnings Guidance
August 11th Morning Report
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query